April 19, 2017
Podcast
Speaker: Roger Longman
Real Endpoints LLC
In this episode of BioTalk, Locust Walk’s Vice President, Josh Hamermesh, spoke to Roger Longman, CEO of Real Endpoints, about the pricing and reimbursement issues that are affecting the biopharmaceutical industry, with a particular focus on the impact on deal making. Highlights of the conversation include:
April 16, 2026 11am ET
Susan Raiola, President, Real Endpoints
Rob Holmes, VP, Patient Experience & Reimbursement, GSK
Ilias Kifnidis, Head of Patient Services, Genmab
November 4, 2025 11am ET
Jane Barlow, Chief Clinical Officer and Senior Advisor to Tufts NEWDIGS
Dr. Michael Sherman, Former Chief Medical Officer, Point32Health
Chronis Manolis, Former Chief Pharmacy Officer, UPMC
A Webinar with the Payer Execs Who Made the Decisions
April 27, 2025 - May 1, 2025
Las Vegas, NV
The Real Endpoints team will be on the ground for Asembia’s AXS25 Summit April 27 – May 1 to discuss market access, pricing and contracting, and patient support services.
April 28, 2024 - May 2, 2024
Las Vegas, NV
The Real Endpoints team will be on the ground for Asembia’s AXS24 Summit April 28 – May 2 to discuss market access, pricing and contracting, and patient support services.
April 15, 2024 - April 17, 2024
Cambridge, UK
Jeff Berkowtiz, CEO
The ABI conference is an annual invitation-only gathering of industry leaders, scientists and inventors, and innovators that alternates between Cambridge UK and Cambridge US. On April 16, CEO Jeff Berkowitz will present a talk, “Paying for Innovation.”
April 15, 2024 - April 18, 2024
New Orleans, LA
Rob O'Brien, SVP Specialty
On April 17, Rob O’Brien will join payers and thought leaders at this year’s annual AMCP meeting to discuss prescription digital therapeutics and how to prepare for coverage.
Manager
Payer & Channel Insights, Marketing Analytics & Business Insights